Procalcitonin-guided treatment of respiratory tract infections

American Family Physician

Volumn 78, Issue 6, 2008, Pages 756-757

  Ebell, Mark ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ANTIBIOTIC THERAPY; CALCITONIN BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DISEASE SEVERITY; DYSPNEA; FEVER; HUMAN; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; SHORT SURVEY; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; CALCITONIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROTEIN PRECURSORS; RESPIRATORY TRACT INFECTIONS;

EID: 67549088183     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol. 1998;15(2):202-209. (Pubitemid 28388984)
2. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600-607. (Pubitemid 38264177)
3. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174(1):84-93. (Pubitemid 43955248)
4. Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9-19. (Pubitemid 46122969)
5. Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008;52(1):48-58.